Release of the first injectable drug for obesity in Brazil
Andrea Pereira, MD, Ph.D. - co-founder and former president of the NGO Obesidade Brasil On 01/02/2022, ANVISA (National Health...
Release of the first injectable drug for obesity in Brazil
SUS does not provide drugs to treat obesity
Obesity may affect 30% of the Brazilian population in 2030.
Definitive guide: see the answers to the main questions about nutrition in pregnancy
Vitamin B12 and B1 Deficiency after Bariatric Surgery
Protein, Iron and Copper Deficiency after Bariatric Surgery
Vitamin D, Calcium, and Zinc Deficiency after Bariatric Surgery